PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2016

Oct 14, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2016-10-14

Reporting Person: AUERBACH ALAN H (Director, PRESIDENT AND CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-14	COMMON STOCK	A	150000	$0.00	Acquired	4190000	Direct

Footnotes

F1: Represents Restricted Stock Units which vest in six substantially equal installments on each six-month anniversary of the Vesting Commencement Date of July 19, 2016, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.